Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa

PHASE2CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

November 30, 2016

Conditions
Immune System Diseases
Interventions
BIOLOGICAL

10 HEP/mL Betula verrucosa allergen extract

The investigational product contained 10 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.

BIOLOGICAL

25 HEP/mL Betula verrucosa allergen extract

The investigational product contained 25 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.

BIOLOGICAL

50 HEP/mL Betula verrucosa allergen extract

The investigational product contained 50 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.

BIOLOGICAL

100 HEP/mL Betula verrucosa allergen extract

The investigational product contained 100 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.

Trial Locations (1)

27003

Hospital Lucus Augusti, Lugo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inmunotek S.L.

INDUSTRY

NCT02527187 - Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa | Biotech Hunter | Biotech Hunter